1. Home
  2. GV vs SABS Comparison

GV vs SABS Comparison

Compare GV & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GV
  • SABS
  • Stock Information
  • Founded
  • GV 2013
  • SABS 2014
  • Country
  • GV Canada
  • SABS United States
  • Employees
  • GV N/A
  • SABS N/A
  • Industry
  • GV Other Consumer Services
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GV Real Estate
  • SABS Health Care
  • Exchange
  • GV Nasdaq
  • SABS Nasdaq
  • Market Cap
  • GV 8.5M
  • SABS 15.8M
  • IPO Year
  • GV 2022
  • SABS N/A
  • Fundamental
  • Price
  • GV $1.75
  • SABS $1.78
  • Analyst Decision
  • GV
  • SABS Strong Buy
  • Analyst Count
  • GV 0
  • SABS 5
  • Target Price
  • GV N/A
  • SABS $11.40
  • AVG Volume (30 Days)
  • GV 105.1K
  • SABS 34.2K
  • Earning Date
  • GV 05-20-2025
  • SABS 05-19-2025
  • Dividend Yield
  • GV N/A
  • SABS N/A
  • EPS Growth
  • GV N/A
  • SABS N/A
  • EPS
  • GV N/A
  • SABS N/A
  • Revenue
  • GV $7,773,905.00
  • SABS $1,322,410.00
  • Revenue This Year
  • GV N/A
  • SABS N/A
  • Revenue Next Year
  • GV N/A
  • SABS $50.00
  • P/E Ratio
  • GV N/A
  • SABS N/A
  • Revenue Growth
  • GV N/A
  • SABS N/A
  • 52 Week Low
  • GV $1.00
  • SABS $1.00
  • 52 Week High
  • GV $9.60
  • SABS $5.01
  • Technical
  • Relative Strength Index (RSI)
  • GV 36.51
  • SABS 58.36
  • Support Level
  • GV $1.71
  • SABS $1.53
  • Resistance Level
  • GV $1.83
  • SABS $1.85
  • Average True Range (ATR)
  • GV 0.16
  • SABS 0.15
  • MACD
  • GV 0.03
  • SABS 0.02
  • Stochastic Oscillator
  • GV 13.24
  • SABS 73.68

About GV Visionary Education Technology Holdings Group Inc.

Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: